Skip to main content
SpringerLink
Log in

Passive and Carrier-Mediated Intestinal Absorption Components of Two Angiotensin Converting Enzyme (ACE) Inhibitor Prodrugs in Rats: Enalapril and Fosinopril

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The intestinal absorption mechanism of two ACE inhibitor prodrugs, enalapril and fosinopril, was investigated in rats using a single-pass perfusion method. A modified boundary layer solution was applied to determine the apparent intestinal wall permeability. The prodrug enalapril is well absorbed from rat jejunum, whereas the parent drug, enalaprilat, is poorly absorbed. The permeability of enalapril is concentration dependent and is decreased by the dipeptide Tyr-Gly and by cephradine but not by the amino acids L-leucine or L-phenylalanine, indicating a nonpassive absorption mechanism via the small peptide carrier-mediated transport system. In contrast, fosinopril is readily absorbed by a concentration-independent mechanism without the involvement of the peptide carrier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. M. Hu and G. L. Amidon. J. Pharm. Sci. 77:1007–1011 (1988).

    Google Scholar 

  2. A. F. Lant. Br. J. Clin. Pharmac. 23:27S–41S (1987).

    Google Scholar 

  3. J. Bussien, T. F. D'Amore, L. Perret, M. Prchet, J. Nussberger, B. Waeber, and H. R. Brunner. Clin. Pharmacol. Ther. 39:554–558 (1986).

    Google Scholar 

  4. F. Fyhrquist. Drugs 32(Suppl.5):33–39 (1986).

    Google Scholar 

  5. N. Nakashima and K. Nishijima. Clin. Sci. 63(Suppl.8):183–185 (1982).

    Google Scholar 

  6. P. H. Vlasses, G. E. Larijani, D. P. Conner, and R. K. Ferguson. Clin. Pharm. 4:27–40 (1985).

    Google Scholar 

  7. E. A. DeFelice and J. B. Kostis. In E. A. DeFelice and J. B. Kostis (eds.), Angiotensin Converting Enzyme Inhibitors, Alan R. Liss, New York, 1987, pp. 213–261.

    Google Scholar 

  8. C. R. Gardner. In R. T. Borchardt, A. J. Repta and V. J. Stella (eds.), Directed Drug Delivery, Humana Press, Clifton, N.J., 1985, pp. 61–82.

    Google Scholar 

  9. K. S. Pang, W. F. Cherry, and E. H. Ulm. J. Pharmacol. Exp. Ther. 233:788–795 (1985).

    Google Scholar 

  10. D. A. Johnson and G. L. Amidon. J. Theor. Biol. 131:93–106 (1988).

    Google Scholar 

  11. P. J. Sinko and G. L. Amidon. Pharm. Res. 5:645–650 (1988).

    Google Scholar 

  12. P. J. Sinko and G. L. Amidon. Submitted for publication.

  13. D. J. Tocco, F. A. Deluna, A. E. Duncan, T. C. Vassil, and E. H. Ulm. Drug Metabol. Disp. 10:15–19 (1982).

    Google Scholar 

  14. G. L. Amidon, P. J. Sinko, and D. Fleisher. Pharm. Res. 5:651–654 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-1065

    Doron I. Friedman

Authors
  1. Doron I. Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gordon L. Amidon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedman, D.I., Amidon, G.L. Passive and Carrier-Mediated Intestinal Absorption Components of Two Angiotensin Converting Enzyme (ACE) Inhibitor Prodrugs in Rats: Enalapril and Fosinopril. Pharm Res 6, 1043–1047 (1989). https://doi.org/10.1023/A:1015978420797

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015978420797

Search

Navigation